AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Nicotine addiction is a chronic condition with a very high rate of relapse. Pharmacologic agents significantly increase a person's chances of quitting, particularly when used as part of a comprehensive plan that also includes counseling and peer support.
In 2000, governmental and nonprofit organizations issued the clinical practice guideline "Treating Tobacco Use and Dependence." TTUD lists five products as first-line agents: sustained-release bupropion and four nicotine-replacement products (gum, patch, nasal spray, and inhaler). A nicotine lozenge is also available now.
Patient preference is the biggest determinant of product choice. Within each product category, experts see no difference between the prescription and over-the-counter formulations. Sustained-release bupropion (Zyban) is the only nonnicotine product currently approved as a first-line agent. It can be used as monotherapy or combined with nicotine replacement.
Clonidine and nortriptyline are considered secondline agents. They are not approved by the Food and Drug Administration for this indication, but there is evidence that they make smoking cessation easier.
Patients should start bupropion 1-2 weeks before they stop smoking, to achieve a therapeutic level by the time they quit. Nicotine replacement agents should be started after a patient stops smoking. Information on the activity of nicotine replacement therapy in elderly people is scarce. It's believed that no special dosage adjustments are necessary.
Pregnant women who smoke are urged to use nonpharmacologic means to help them quit. The TTUD states that pharmacologic interventions should be used only if the increased likelihood of abstinence, with its potential benefits, outweighs the risks of drug treatment. If a woman uses nicotine replacement during lactation, the nicotine is excreted into milk, making it safest not to breast-feed. However, both the patch and gum are preferable to smoking if there is no other alternative. There is some evidence that first-trimester bupropion exposure may be related to cardiovascular defects, but additional data are required to confirm this association. Bupropion is also excreted into milk. Although no adverse effects have been noted in nursing infants, the American Academy of Pediatrics has expressed concern that long-term exposure could harm the central nervous system function of these infants. Pregnant women should not start using clonidine because it might cause maternal hypotension and thus decrease placental perfusion. This does not appear to be a risk if the drug is started before pregnancy. Nortriptyline use has not been associated with structural anomalies in developing fetuses, but there have been reports of urinary retention in neonates who had drug exposure in utero. Both clonidine and nortriptyline are excreted into breast milk. There have been no reports of adverse effects in exposed infants.
NICOTINE REPLACEMENT
Drug Cost/Day* Dosage
gum $7.20 (2 mg, 20/day) as needed
[Nicorette] [$8.80]
inhaler no generic available 6-16
[Nicotrol inhaler] [$9.70 (10 cartridges/day
cartridges)]
lozenge no generic available every 1-2
[Commit] [$5.28 (2 mg, hours, then
12/day)] taper
nasal spray no generic available 1 spray into
[Nicotrol NS] [$8.20 (20 mg)] each nostril,
as needed
transdermal patch $2.13 (OTC. 14 mg) 1 patch/day
$6.29 (prescription)
[Habitrol] [$4.73]
[Nicoderm] [$3.39]
[Nicotrol] [$3.53]
OTHER AGENTS
bupropion $2.88 150 mg
[Zyban] [$4.14] b.i.d.
clonidine patch no generic available
[Catapres-TTS] [$2.08 (0.1 mg)] 0.1-0.3
mg/day
nortriptyline $0.14
[Aventyl] [$1.05] 25 mg/day
[Pamelor] [$4.26]
Drug What the Experts Say**
gum All products are over the counter (OTC). Patients
[Nicorette] chew one piece when they have an urge to smoke. The
2-mg formulation should not be used more than 30
times/day if under a doctor's supervision, or more
than 24/day by patients quitting on their own. Use
of the 4-mg strength should not exceed 24
pieces/day. Should not be used for more than 12
weeks. Some experts suggest patients cut use by one
piece every 4-7 days, substituting sugarless gum it
necessary. Patients should also try to drop mouth
time from 30 minutes per piece to 10-15 minutes.
Should not be swallowed. Acidic beverages should be
avoided 15 minutes before and after use.
inhaler Available in trade formulation only. Prescription
[Nicotrol inhaler] product. Satisfies ...
Source: HighBeam Research, Smoking cessation.(DRUG UPDATE)